
Anish Gupta
Examiner (ID: 1129)
| Most Active Art Unit | 1654 |
| Art Unit(s) | PCTL, 1653, IPLA, 1811, 1654, 6221 |
| Total Applications | 1025 |
| Issued Applications | 530 |
| Pending Applications | 180 |
| Abandoned Applications | 323 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6543908
[patent_doc_number] => 20100204673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'OBESITY CONTROLLING METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/566886
[patent_app_country] => US
[patent_app_date] => 2009-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1368
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204673.pdf
[firstpage_image] =>[orig_patent_app_number] => 12566886
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/566886 | OBESITY CONTROLLING METHOD | Sep 24, 2009 | Abandoned |
Array
(
[id] => 6602766
[patent_doc_number] => 20100062976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Synthesis of Cyclosporin Analogs'
[patent_app_type] => utility
[patent_app_number] => 12/555787
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26969
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062976.pdf
[firstpage_image] =>[orig_patent_app_number] => 12555787
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/555787 | Synthesis of Cyclosporin Analogs | Sep 7, 2009 | Abandoned |
Array
(
[id] => 5398297
[patent_doc_number] => 20090318360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Use of the neurotoxic component of a botulinum toxin for treating arthritis'
[patent_app_type] => utility
[patent_app_number] => 12/550331
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4212
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318360.pdf
[firstpage_image] =>[orig_patent_app_number] => 12550331
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/550331 | Use of the neurotoxic component of a botulinum toxin for treating arthritis | Aug 27, 2009 | Issued |
Array
(
[id] => 6412894
[patent_doc_number] => 20100166782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/508543
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 68057
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166782.pdf
[firstpage_image] =>[orig_patent_app_number] => 12508543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/508543 | CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION | Jul 22, 2009 | Abandoned |
Array
(
[id] => 5464507
[patent_doc_number] => 20090324707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/499500
[patent_app_country] => US
[patent_app_date] => 2009-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7717
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324707.pdf
[firstpage_image] =>[orig_patent_app_number] => 12499500
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/499500 | METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES | Jul 7, 2009 | Abandoned |
Array
(
[id] => 5464507
[patent_doc_number] => 20090324707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/499500
[patent_app_country] => US
[patent_app_date] => 2009-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7717
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324707.pdf
[firstpage_image] =>[orig_patent_app_number] => 12499500
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/499500 | METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES | Jul 7, 2009 | Abandoned |
Array
(
[id] => 6275317
[patent_doc_number] => 20100256074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'Processes for preparing high purity aza cyclohexapeptides'
[patent_app_type] => utility
[patent_app_number] => 12/459180
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6688
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256074.pdf
[firstpage_image] =>[orig_patent_app_number] => 12459180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/459180 | Processes for preparing high purity aza cyclohexapeptides | Jun 24, 2009 | Abandoned |
Array
(
[id] => 4496128
[patent_doc_number] => 07947654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-24
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 12/487116
[patent_app_country] => US
[patent_app_date] => 2009-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9485
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/947/07947654.pdf
[firstpage_image] =>[orig_patent_app_number] => 12487116
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/487116 | Pharmaceutical formulations | Jun 17, 2009 | Issued |
Array
(
[id] => 6317196
[patent_doc_number] => 20100112619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'LIGAND-CONTAINING MICELLES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/469597
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 47902
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112619.pdf
[firstpage_image] =>[orig_patent_app_number] => 12469597
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/469597 | LIGAND-CONTAINING MICELLES AND USES THEREOF | May 19, 2009 | Abandoned |
Array
(
[id] => 5398604
[patent_doc_number] => 20090318667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Peptoid compositions and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 12/454381
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8736
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 86
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318667.pdf
[firstpage_image] =>[orig_patent_app_number] => 12454381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454381 | Peptoid compositions and methods of using the same | May 14, 2009 | Abandoned |
Array
(
[id] => 5398273
[patent_doc_number] => 20090318336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Deuterated Cyclosporine Analogs and Methods of Making the Same'
[patent_app_type] => utility
[patent_app_number] => 12/427692
[patent_app_country] => US
[patent_app_date] => 2009-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10757
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318336.pdf
[firstpage_image] =>[orig_patent_app_number] => 12427692
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/427692 | Deuterated Cyclosporine Analogs and Methods of Making the Same | Apr 20, 2009 | Abandoned |
Array
(
[id] => 5545985
[patent_doc_number] => 20090155862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Process for the preparation of 2-hydroxymethyl-pyrrolidine-3,4-diols'
[patent_app_type] => utility
[patent_app_number] => 12/379297
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4527
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155862.pdf
[firstpage_image] =>[orig_patent_app_number] => 12379297
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/379297 | Process for the preparation of 2-hydroxymethyl-pyrrolidine-3,4-diols | Feb 17, 2009 | Abandoned |
Array
(
[id] => 5403543
[patent_doc_number] => 20090238857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'USE OF HYDROPHOBIC CROSSLINKING AGENTS TO PREPARE CROSSLINKED BIOMATERIAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/388134
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7952
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388134
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388134 | USE OF HYDROPHOBIC CROSSLINKING AGENTS TO PREPARE CROSSLINKED BIOMATERIAL COMPOSITIONS | Feb 17, 2009 | Abandoned |
Array
(
[id] => 5472967
[patent_doc_number] => 20090246133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'METHODS AND COMPOSITIONS RELATED TO INTERNALIZING RGD PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/355672
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 23038
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246133.pdf
[firstpage_image] =>[orig_patent_app_number] => 12355672
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/355672 | Methods and compositions related to internalizing RGD peptides | Jan 15, 2009 | Issued |
Array
(
[id] => 8421784
[patent_doc_number] => 08278272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'GLP-1, exendin-4, peptide analogs and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/317042
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 38
[patent_no_of_words] => 26288
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12317042
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/317042 | GLP-1, exendin-4, peptide analogs and uses thereof | Dec 17, 2008 | Issued |
Array
(
[id] => 5546628
[patent_doc_number] => 20090156505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'SELF-ASSEMBLY AND MINERALIZATION OF PEPTIDE-AMPHIPHILE NANOFIBERS'
[patent_app_type] => utility
[patent_app_number] => 12/330468
[patent_app_country] => US
[patent_app_date] => 2008-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7169
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156505.pdf
[firstpage_image] =>[orig_patent_app_number] => 12330468
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/330468 | Self-assembly and mineralization of peptide-amphiphile nanofibers | Dec 7, 2008 | Issued |
Array
(
[id] => 5380450
[patent_doc_number] => 20090192289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'OMI PDZ MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/270517
[patent_app_country] => US
[patent_app_date] => 2008-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26619
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192289.pdf
[firstpage_image] =>[orig_patent_app_number] => 12270517
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/270517 | OMI PDZ MODULATORS | Nov 12, 2008 | Abandoned |
Array
(
[id] => 5564642
[patent_doc_number] => 20090137495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Organic Compounds and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 12/249186
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29274
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137495.pdf
[firstpage_image] =>[orig_patent_app_number] => 12249186
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/249186 | Organic compounds and their uses | Oct 9, 2008 | Issued |
Array
(
[id] => 5539985
[patent_doc_number] => 20090221790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS'
[patent_app_type] => utility
[patent_app_number] => 12/247119
[patent_app_country] => US
[patent_app_date] => 2008-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10265
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221790.pdf
[firstpage_image] =>[orig_patent_app_number] => 12247119
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/247119 | METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS | Oct 6, 2008 | Abandoned |
Array
(
[id] => 4442281
[patent_doc_number] => 07928065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-19
[patent_title] => 'Methods of treatment using exendin peptides or GLP-1 peptides'
[patent_app_type] => utility
[patent_app_number] => 12/247141
[patent_app_country] => US
[patent_app_date] => 2008-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23813
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/928/07928065.pdf
[firstpage_image] =>[orig_patent_app_number] => 12247141
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/247141 | Methods of treatment using exendin peptides or GLP-1 peptides | Oct 6, 2008 | Issued |